Stay updated on Resmetirom Safety and Biomarkers Clinical Trial
Sign up to get notified when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.

Latest updates to the Resmetirom Safety and Biomarkers Clinical Trial page
- Check4 days agoChange DetectedRemoved references to non-alcoholic fatty liver disease and related topics, including MedlinePlus Genetics.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated to v3.5.0; the prior revision, v3.4.3, is no longer displayed.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 was added and a generic funding/operational notice was removed; these are administrative updates to the website. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedA government funding status notice was added at the top of the page and the revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check68 days agoChange DetectedShow glossary was added to the page, and labels related to QC updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data) were adjusted in capitalization; a new revision note 'Revision: v3.4.0' was added and older notes removed ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Resmetirom Safety and Biomarkers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.